163 related articles for article (PubMed ID: 38284772)
21. Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease.
Qi W; Liu L; Zeng Q; Zhou Z; Chen D; He B; Gong S; Gao L; Wang X; Xiong J; Cai D; Yu S; Zhao L
J Cell Mol Med; 2023 Dec; 27(24):4034-4044. PubMed ID: 37801050
[TBL] [Abstract][Full Text] [Related]
22. Adrenomedullin/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis.
Wang X; Jia JH; Zhang M; Meng QS; Yan BW; Ma ZY; Wang DB
FASEB J; 2023 Oct; 37(10):e23143. PubMed ID: 37698353
[TBL] [Abstract][Full Text] [Related]
23. Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis.
Li G; Peng L; Wu M; Zhao Y; Cheng Z; Li G
Front Immunol; 2022; 13():1039510. PubMed ID: 36601107
[TBL] [Abstract][Full Text] [Related]
24. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z
Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Liu H; Tang T
Front Oncol; 2022; 12():952290. PubMed ID: 36276096
[TBL] [Abstract][Full Text] [Related]
26. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
Bian Z; Fan R; Xie L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
[TBL] [Abstract][Full Text] [Related]
27. Research progress in cuproptosis in liver cancer.
Chen L; Liu D; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
[TBL] [Abstract][Full Text] [Related]
28. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
29. Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease.
Li H; Fu Y; Xu Y; Miao H; Wang H; Zhang T; Mei X; He Y; Zhang A; Ge X
Am J Physiol Cell Physiol; 2024 May; ():. PubMed ID: 38798269
[TBL] [Abstract][Full Text] [Related]
30. The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma.
Lei G; Tang L; Yu Y; Bian W; Yu L; Zhou J; Li Y; Wang Y; Du J
Biomed Pharmacother; 2023 Nov; 167():115522. PubMed ID: 37757497
[TBL] [Abstract][Full Text] [Related]
31. A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis.
Cui Y; Chen Y; Gan N; Li M; Liao W; Zhou Y; Xiang Q; Gong X; Guo Q; Hu P; Zheng XL; Shang D; Peng J; Tang Z
Mol Biomed; 2023 Jul; 4(1):21. PubMed ID: 37442861
[TBL] [Abstract][Full Text] [Related]
32. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
Johnson L; Barnard JJ; Rodriguez L; Smith EC; Swerdloff RS; Wang XH; Wang C
J Androl; 1998; 19(3):348-57. PubMed ID: 9639052
[TBL] [Abstract][Full Text] [Related]
33. Zinc Supplementation Reduces Testicular Cell Apoptosis in Mice and Improves Spermatogenic Dysfunction Caused by Marginal Zinc Deficiency.
Zeng X; Wang Z; Yu L; Wang L; Liu Y; Chen Y; Wang C
Biol Trace Elem Res; 2024 Apr; 202(4):1656-1668. PubMed ID: 37515670
[TBL] [Abstract][Full Text] [Related]
34. Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1.
Quan Y; Li W; Yan R; Cheng J; Xu H; Chen L
Front Oncol; 2023; 13():1168769. PubMed ID: 37361595
[TBL] [Abstract][Full Text] [Related]
35. Fold-change correction values for testicular somatic transcripts in gene expression studies of human spermatogenesis.
Cappallo-Obermann H; Feig C; Schulze W; Spiess AN
Hum Reprod; 2013 Mar; 28(3):590-8. PubMed ID: 23303554
[TBL] [Abstract][Full Text] [Related]
36. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
37. Cuproptosis-related gene
Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
Front Immunol; 2022; 13():999823. PubMed ID: 36225932
[TBL] [Abstract][Full Text] [Related]
38. LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.
Quan B; Liu W; Yao F; Li M; Tang B; Li J; Ren Z; Yin X
Am J Cancer Res; 2023; 13(11):5590-5609. PubMed ID: 38058825
[TBL] [Abstract][Full Text] [Related]
39. Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator
Zeng S; Zhang H; Zhang D; Hu X; Song L
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292610
[TBL] [Abstract][Full Text] [Related]
40. Changes in cuproptosis-related gene expression in periodontitis: An integrated bioinformatic analysis.
Liu N; He Y; Chen X; Qiu G; Wu Y; Shen Y
Life Sci; 2024 Feb; 338():122388. PubMed ID: 38181851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
